1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: SI2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: YF4
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: FI6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: MB8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: TW3
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: AV6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: VG3
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: EE8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: GI1
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 1
STUDY DRUG CODE: OQ2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: XH6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: AC7
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: WM2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: NH2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: PZ8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: XK4
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: KW6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: ZY6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: TM3
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 2
STUDY DRUG CODE: LF3
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: YE5
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: YB0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: OZ0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: WE4
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: WZ0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: NV9
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: HS6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: LQ8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: IL8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 3
STUDY DRUG CODE: LP9
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: ZH5
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: SD9
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: BR9
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: AP7
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: HQ2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: SC3
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: XU9
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: TW0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: NT5
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 4
STUDY DRUG CODE: MA0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: GL7
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: AH6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: VD7
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: HE0
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: CU1
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: HO8
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: HL2
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: UE4
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: VK5
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1
1.14.4. Investigational Drug Labeling
STRI Phase 2 Clinical Trial Study Drug (650 mg/capsule)
60 capsules per bottle
For oral consumption ONLY - Take 3 capsules by mouth twice a day for 10 days.
Take with 8 ounces of water, either 1 hour before or 2 hours after any food intake.
Batch/Lot Number: 5
STUDY DRUG CODE: KA6
Store the study drug in a cool (no more than room temperature), dry place and take the study drug as instructed.
Room temperature is defined as 68–72°F (20–22 °C).
Caution: New Drug – Limited by Federal (or United States) law to investigational use.
Sponsor: Eyecheck, Inc., Oak Forest, IL 60452
1